Balance Sheet
Accumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Diversified Healthcare Trust (DHCNL) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Diversified Healthcare Trust (DHCNL) over the last 17 years, with Q3 2025 value amounting to $201.4 million.

  • Diversified Healthcare Trust's Cash & Equivalents fell 2150.11% to $201.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $201.4 million, marking a year-over-year decrease of 2150.11%. This contributed to the annual value of $144.6 million for FY2024, which is 4121.14% down from last year.
  • Latest data reveals that Diversified Healthcare Trust reported Cash & Equivalents of $201.4 million as of Q3 2025, which was down 2150.11% from $141.8 million recorded in Q2 2025.
  • Diversified Healthcare Trust's Cash & Equivalents' 5-year high stood at $849.1 million during Q2 2021, with a 5-year trough of $141.8 million in Q2 2025.
  • For the 5-year period, Diversified Healthcare Trust's Cash & Equivalents averaged around $456.3 million, with its median value being $338.4 million (2023).
  • In the last 5 years, Diversified Healthcare Trust's Cash & Equivalents skyrocketed by 111250.56% in 2021 and then crashed by 6262.69% in 2023.
  • Over the past 5 years, Diversified Healthcare Trust's Cash & Equivalents (Quarter) stood at $634.8 million in 2021, then increased by 3.66% to $658.1 million in 2022, then crashed by 62.63% to $245.9 million in 2023, then plummeted by 41.21% to $144.6 million in 2024, then skyrocketed by 39.28% to $201.4 million in 2025.
  • Its Cash & Equivalents was $201.4 million in Q3 2025, compared to $141.8 million in Q2 2025 and $302.6 million in Q1 2025.